What if a blood test could reveal the pace of our aging—and the diseases that may lie ahead? The labs of Profs. Liran Shlush ...

A new study shows that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...

New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment outcomes for pediatric ...

Porton Advanced Solutions and EVA Pharma have signed an MoU to enhance the development capabilities for CAR T-cell therapies.

Investigation reveals cancer drugs failing quality tests worldwide, including cisplatin, oxaliplatin, cyclophosphamide, ...

A Honduran woman filed a lawsuit challenging the legality of her and her family’s detention at a Texas facility. She is also ...

Numerous businesses in Acadiana have come together for a benefit being held in support of a local boy, Fisher, and his family ...

EVA Pharma & Porton Advanced Solutions ink MoU to expand CAR T-cell therapy access in Middle East and Africa: Suzhou, Cairo Friday, June 27, 2025, 16:00 Hrs [IST] EVA Pharma, one ...

The report indicates >25 clinical trials, with the highest phase being Phase II/III as of June 2025. The US and China lead with >20 trials. Gamma Delta T Cell therapy, promising in treating blood ...

June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as ...

EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 70 countries worldwide. For more ...